PSEN2 and Alzheimer disease: In the initial development of the induced pluripotent stem cell (iPSC) AD model in fibroblasts from Alzheimer's patients with PS1 (A246E) mutations and PS2 (N141I) mutations, the ability to differentiate between neurons and those with the PS1 mutations and PS2 mutations is a distinguishing feature.